Benjamin J. Zeskind - PRESIDENT AND CEO, Director, 10%+ Owner at Immuneering Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
PRESIDENT AND CEO, Director, 10%+ Owner
Stock Symbol
IMRX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Benjamin J. Zeskind - trading volume in the past year for Immuneering Corp

Holdings reported by Benjamin J. Zeskind for Immuneering Corp

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 2.31M $3.35M $1.45 Jul 2, 2025 Direct
Class A Common Stock 895K $1.3M $1.45 Jul 1, 2025 Indirect
Stock Option 480K Feb 5, 2025 Direct Class A Common Stock

Transactions reported by Benjamin J. Zeskind for Immuneering Corp

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.